Generation Bio Competitors and Similar CompaniesClear all
Generation Bio's competitors and similar companies include Cimeio and Adverum Biotechnologies.
 Cimeio Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases. |  Adverum Biotechnologies Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases. | ||
Founding Date | Founding Date 2016 | Founding Date 2020 | Founding Date 2006 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Basel, CH HQ | Locations Redwood City, US HQ Philadelphia, US |
Employees | Employees 85 | Employees 21 | Employees 11419% increase |
Valuation ($) | Valuation ($) 159.5 m | Valuation ($) N/A | Valuation ($) 161.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) $19.9m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) $1m (FY, 2024) |
Net income | Net income ($131.7m) (FY, 2024) | Net income N/A | Net income ($130.9m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 235m | Total funding raised $ 50m | Total funding raised $ 70.7m |
For sources of this data, please see the company profile
View Company Profiles
Cimeio
HQ
Basel, CH
Employees
21
Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases.
View companyAdverum Biotechnologies
HQ
Redwood City, US
Employees
114↑ 19% increase
Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases.
View company